Business · 1 sources covering this

Aragen Life Sciences Files DRHP With SEBI For IPO; Eyes Rs 800 Crore Via Fresh Issue

Axis Capital, Citigroup Global Markets India, Goldman Sachs (India) Securities and JM Financial are the book-running lead managers to the proposed IPO.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·1h ago
Aragen Life Sciences Files DRHP With SEBI For IPO; Eyes Rs 800 Crore Via Fresh Issue
Axis Capital, Citigroup Global Markets India, Goldman Sachs (India) Securities and JM Financial are the book-running lead managers to the proposed IPO.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/2ad85bd6a352f1372a4d71f0889596ae23b16bbf"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Aragen Life Sciences Files DRHP With SEBI For IPO; Eyes Rs 800 Crore Via Fresh Issue"></iframe>

Aragen Life Sciences Files DRHP With SEBI For IPO; Eyes Rs 800 Crore Via Fresh Issue

How 1 sources are covering this

Aragen Life Sciences Files DRHP With SEBI For IPO; Eyes Rs 800 Crore Via Fresh Issue

More from Business

HDFC Bank Mulls Challenging NCLT Order Granting Subhash Chandra 99.97% Debt Haircut

Paramotor Digital Technology Secures SEBI Nod For IPO

IPO-Bound OYO Parent Prism Reports Four-Fold Jump In Net Profit To Rs 994 Crore In FY2025-26

Nvidia Q2 Ripple Effect: SanDisk, Micron, SK Hynix, Intel, Other Chipmakers Spike 5% Pre-Market

Reader

Trust & legal

Across the network